» Articles » PMID: 36465578

A Friend or a Foe? Bariatric Surgery in Chronic Kidney Disease: A Case Report

Overview
Specialty Nephrology
Date 2022 Dec 5
PMID 36465578
Authors
Affiliations
Soon will be listed here.
Abstract

There has been a parallel rise in the need for bariatric surgery as the prevalence of obesity has increased by leaps and bounds over the last 2 decades. Certain procedures like Roux-en-Y gastric bypass are associated with nephrolithiasis, hyperoxaluria, and, rarely, oxalate nephropathy. We report an interesting case of a patient who had relentless progression of his kidney disease post-bariatric surgery.

References
1.
Bagby S . Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?. J Am Soc Nephrol. 2004; 15(11):2775-91. DOI: 10.1097/01.ASN.0000141965.28037.EE. View

2.
Wang Y, Chen X, Song Y, Caballero B, Cheskin L . Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2007; 73(1):19-33. DOI: 10.1038/sj.ki.5002586. View

3.
Sjostrom L, Narbro K, Sjostrom C, Karason K, Larsson B, Wedel H . Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357(8):741-52. DOI: 10.1056/NEJMoa066254. View

4.
Navaneethan S, Kelly K, Sabbagh F, Schauer P, Kirwan J, Kashyap S . Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010; 20(3):308-15. PMC: 2891346. DOI: 10.1007/s11695-009-0026-1. View

5.
Nasr S, DAgati V, Said S, Stokes M, Largoza M, Radhakrishnan J . Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol. 2008; 3(6):1676-83. PMC: 2572276. DOI: 10.2215/CJN.02940608. View